trifluridine ophthalmic
Selected indexed studies
- Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models. (J Med Virol, 2024) [PMID:38180134]
- Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. (Ophthalmology, 1994) [PMID:7997323]
- Herpes simplex uveitis. (Bol Asoc Med P R, 2004) [PMID:15580909]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. (2012) pubmed
- Trifluridine for treatment of mpox infection in drug combinations in ophthalmic cell models. (2024) pubmed
- Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. (1994) pubmed
- Herpes simplex uveitis. (2004) pubmed
- Ocular manifestations of mpox. (2024) pubmed
- Monkeypox Virus and Ophthalmology-A Primer on the 2022 Monkeypox Outbreak and Monkeypox-Related Ophthalmic Disease. (2023) pubmed
- Intraocular penetration of trifluridine. (1979) pubmed
- Monkeypox as an emerging infectious disease: the ophthalmic implications. (2022) pubmed
- Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections. (1982) pubmed
- Management of herpes simplex virus epithelial keratitis. (2018) pubmed